Voutsadakis Ioannis A
1 Division of Medical Oncology, Department of Internal Medicine, Sault Area Hospital, Sault Ste. Marie, ON, Canada.
2 Division of Clinical Sciences, Northern Ontario School of Medicine, Sudbury, ON, Canada.
Tumour Biol. 2017 Mar;39(3):1010428317692248. doi: 10.1177/1010428317692248.
Proteasome is a multi-protein organelle that participates in cellular proteostasis by destroying damaged or short-lived proteins in an organized manner guided by the ubiquitination signal. By being in a central place in the cellular protein complement homeostasis, proteasome is involved in virtually all cell processes including decisions on cell survival or death, cell cycle, and differentiation. These processes are important also in cancer, and thus, the proteasome is an important regulator of carcinogenesis. Cancers include a variety of cells which, according to the cancer stem cell theory, descend from a small percentage of cancer stem cells, alternatively termed tumor-initiating cells. These cells constitute the subsets that have the ability to propagate the whole variety of cancer and repopulate tumors after cytostatic therapies. Proteasome plays a role in cellular processes in cancer stem cells, but it has been found to have a decreased function in them compared to the rest of cancer cells. This article will discuss the transcriptional regulation of proteasome sub-unit proteins in cancer and in particular cancer stem cells and the relationship of the proteasome with the pluripotency that is the defining characteristic of stem cells. Therapeutic opportunities that present from the understanding of the proteasome role will also be discussed.
蛋白酶体是一种多蛋白细胞器,它通过在泛素化信号的引导下有组织地破坏受损或寿命较短的蛋白质来参与细胞蛋白质稳态。由于蛋白酶体在细胞蛋白质补充稳态中处于核心地位,它几乎参与了所有细胞过程,包括细胞生存或死亡的决定、细胞周期和分化。这些过程在癌症中也很重要,因此,蛋白酶体是致癌作用的重要调节因子。癌症包括多种细胞,根据癌症干细胞理论,这些细胞来源于一小部分癌症干细胞,也被称为肿瘤起始细胞。这些细胞构成了能够繁殖整个癌症种类并在细胞抑制疗法后重新填充肿瘤的亚群。蛋白酶体在癌症干细胞的细胞过程中发挥作用,但已发现它在这些细胞中的功能比其他癌细胞有所降低。本文将讨论癌症尤其是癌症干细胞中蛋白酶体亚基蛋白的转录调控,以及蛋白酶体与干细胞的定义特征——多能性之间的关系。还将讨论从理解蛋白酶体作用中产生的治疗机会。